Abstract
Kim BK, Hong SJ, Lee YJ, et al. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial. Lancet. 202;400:380-90. 35863366.
MeSH terms
-
Anticholesteremic Agents / therapeutic use
-
Atherosclerosis* / drug therapy
-
Drug Therapy, Combination / adverse effects
-
Equivalence Trials as Topic
-
Ezetimibe* / therapeutic use
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
-
Randomized Controlled Trials as Topic
-
Treatment Outcome
Substances
-
Anticholesteremic Agents
-
Ezetimibe
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors